July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Binocular vision disorders and contact lens dissatisfaction
Author Affiliations & Notes
  • Daniel Tilia
    Clinical Research and Trials Centre, Brien Holden Vision Institute, Sydney, New South Wales, Australia
    School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia
  • Ravi Chandra Bakaraju
    Clinical Research and Trials Centre, Brien Holden Vision Institute, Sydney, New South Wales, Australia
    School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia
  • Lisa J Asper
    School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia
  • Eric Papas
    School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia
  • Footnotes
    Commercial Relationships   Daniel Tilia, None; Ravi Bakaraju, None; Lisa Asper, None; Eric Papas, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6369. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Daniel Tilia, Ravi Chandra Bakaraju, Lisa J Asper, Eric Papas; Binocular vision disorders and contact lens dissatisfaction. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6369.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine the effect of binocular vision disorders (BVDs) on contact lens (CL)-dissatisfaction.

Methods : This was a prospective study where 76 myopic, non-presbyopic CL wearers attended one visit while wearing habitual CLs.
BVD and CL discomfort (CLD) symptoms were assessed via the convergence insufficiency syndrome survey (CISS) and the contact lens dry eye questionnaire-8 (CLDEQ-8), respectively. Participants (Pxs) underwent a comprehensive BV assessment and were categorised into 3 groups according to their BV-status:
1. Normal (N): ≤2 measures outside normal range
2. Abnormal Findings (AF): ≥3 measures outside normal range but no BVD
3. BVD
CLD-status was grouped based on CLDEQ-8 score: non-CLD: ≤11 and CLD≥12.
Pxs were assessed for CL surface characteristics, CL fitting and ocular surface.
CL-dissatisfaction was assessed via the ocular surface disease index (OSDI), contact lens impact on quality-of-life (CLIQ) and ranked symptoms survey (RSS). These were emailed to Pxs at visit completion.
Subjective and clinical data were analysed using general linear model, with significance set at 5%.

Results : BV-status: N=42, AF=17, BVD=17.
CLD-status: non-CLD=37, CLD=39.
OSDI total score was associated with BV-status (p=0.001. BVD vs N / AF (25±13: 11±8 / 10±5.5, p≤0.001) and CLD-status (p=0.003. CLD vs. non-CLD (19±12: 9.1±5.7, p=0.003). The vision subscale of the OSDI was associated with BV-status (p<0.001) but not CLD-status (p=0.33) while the ocular and environmental subscales of the OSDI were associated with CLD-status (p≤0.03) but not BV-status (p≥0.29).
CLIQ was associated with BV-status (p=0.003) but not CLD-status (p=0.09) while RSS was associated with CLD-status (p<0.001) but not BV-status (p=0.91).
CISS was associated with BV-status (p=0.001) and CLD-status (p=0.005).
CLDEQ-8 was not associated with BV-status (p>0.99)
There were no significant associations within BV-status or CLD-status for CL surface or fitting (p≥0.051), or within BV-status for ocular surface (p≥0.10). CLD had a significantly lower fluorescein tear-break-up-time than non-CLD (7.0±3.7: 10±3.6, p=0.001).
There was no significant interaction between BV-status or CLD-status for any questionnaire or clinical variable (p≥0.13).

Conclusions : BVDs contribute to CL-dissatisfaction in addition to CLD. OSDI and its subscales are appropriate measures of CL-dissatisfaction due to BVD and CLD.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×